325 related articles for article (PubMed ID: 22276284)
1. Anticholinergic and sedative medicines - prescribing considerations for people with dementia.
Bell JS; Mezrani C; Blacker N; LeBlanc T; Frank O; Alderman CP; Rossi S; Rowett D; Shute R
Aust Fam Physician; 2012; 41(1-2):45-9. PubMed ID: 22276284
[TBL] [Abstract][Full Text] [Related]
2. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.
Bhattacharya R; Chatterjee S; Carnahan RM; Aparasu RR
Am J Geriatr Pharmacother; 2011 Dec; 9(6):434-41. PubMed ID: 22030114
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive costs and benefits of psychotropic medications in older adults.
Brooks JO; Hoblyn JC
J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):199-214. PubMed ID: 18004007
[TBL] [Abstract][Full Text] [Related]
5. [Drug-induced cognitive impairment].
Shinohara M; Yamada M
Brain Nerve; 2012 Dec; 64(12):1405-10. PubMed ID: 23209067
[TBL] [Abstract][Full Text] [Related]
6. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.
Gill SS; Mamdani M; Naglie G; Streiner DL; Bronskill SE; Kopp A; Shulman KI; Lee PE; Rochon PA
Arch Intern Med; 2005 Apr; 165(7):808-13. PubMed ID: 15824303
[TBL] [Abstract][Full Text] [Related]
7. [Cognition disorders related to psychotropic treatments].
Bazin N
Rev Prat; 1994 Nov; 44(17):2332-5. PubMed ID: 7984942
[TBL] [Abstract][Full Text] [Related]
8. Effects of drug burden index on cognitive function in older men.
Gnjidic D; Le Couteur DG; Naganathan V; Cumming RG; Creasey H; Waite LM; Sharma A; Blyth FM; Hilmer SN
J Clin Psychopharmacol; 2012 Apr; 32(2):273-7. PubMed ID: 22367653
[TBL] [Abstract][Full Text] [Related]
9. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women.
Cao YJ; Mager DE; Simonsick EM; Hilmer SN; Ling SM; Windham BG; Crentsil V; Yasar S; Fried LP; Abernethy DR
Clin Pharmacol Ther; 2008 Mar; 83(3):422-9. PubMed ID: 17713474
[TBL] [Abstract][Full Text] [Related]
10. Use of Medicines with Anticholinergic and Sedative Effect Before and After Initiation of Anti-Dementia Medications.
Gadzhanova S; Roughead E; Robinson M
Drugs Real World Outcomes; 2015 Mar; 2(1):53-60. PubMed ID: 27747617
[TBL] [Abstract][Full Text] [Related]
11. Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.
Robinson M; Rowett D; Leverton A; Mabbott V
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):659-64. PubMed ID: 19548222
[TBL] [Abstract][Full Text] [Related]
12. [Drug-induced Cognitive Impairment].
Shinohara M; Yamada M
Brain Nerve; 2016 Apr; 68(4):421-8. PubMed ID: 27056860
[TBL] [Abstract][Full Text] [Related]
13. [Effect of anticholinergic drugs on cognitive impairment in the elderly].
López-Álvarez J; Zea Sevilla MA; Agüera Ortiz L; Fernández Blázquez MÁ; Valentí Soler M; Martínez-Martín P
Rev Psiquiatr Salud Ment; 2015; 8(1):35-43. PubMed ID: 25087132
[TBL] [Abstract][Full Text] [Related]
14. Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia.
Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Ilomäki J; Elliott RA
Drugs Aging; 2016 Jan; 33(1):37-44. PubMed ID: 26645294
[TBL] [Abstract][Full Text] [Related]
15. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergic medicines use among older adults before and after initiating dementia medicines.
Narayan SW; Pearson SA; Litchfield M; Le Couteur DG; Buckley N; McLachlan AJ; Zoega H
Br J Clin Pharmacol; 2019 Sep; 85(9):1957-1963. PubMed ID: 31046175
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.
Konishi K; Hori K; Uchida H; Watanabe K; Tominaga I; Kimura M; Hosoyamada M; Shibasaki T; Kataoka A; Hachisu M
Psychogeriatrics; 2010 Mar; 10(1):34-8. PubMed ID: 20594285
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergics: theoretical and clinical overview.
Nishtala PS; Salahudeen MS; Hilmer SN
Expert Opin Drug Saf; 2016 Jun; 15(6):753-68. PubMed ID: 26966981
[TBL] [Abstract][Full Text] [Related]
19. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people.
Gnjidic D; Le Couteur DG; Abernethy DR; Hilmer SN
Ann Pharmacother; 2010 Nov; 44(11):1725-32. PubMed ID: 20876826
[TBL] [Abstract][Full Text] [Related]
20. Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities.
Ailabouni N; Mangin D; Nishtala PS
BMJ Open; 2017 Apr; 7(4):e013800. PubMed ID: 28416498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
